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Beta‑thalassemia major (β‑TM) is a transfusion‑dependent thalassemia (TDT) and requires regular blood transfusions (BTs) for the afflicted patients. Total annual 
incidence of symptomatic individuals is estimated at 1 in 100,000 
throughout the world [1]. In India, nearly 12,000 children with TM 
are born every year [1]. According to Thalassemia International 
Federation (TIF), only about 200,000 patients with β‑TM are 
alive and registered and receive regular treatment around the 
world [1,2].
The recommended treatment for TM involves lifelong regular 
BTs usually at 2–5 weekly intervals to maintain pre‑transfusion 
hemoglobin (Hb) level in the range of 9–10.5 g% [2]. This 
transfusion regimen promotes normal growth, allows normal 
physical activities, and adequately suppresses bone marrow 
activity in most patients and minimizes transfusional iron 
accumulation [3]. Iron overload occurs in these patients when 
iron intake is increased over a sustained period of time either as a 
result of repeated packed red blood cells (PRBCs) transfusion or 
increased absorption of iron through gastrointestinal tract (GIT). 
In TDT, contribution of iron absorbed through GIT is 
small compared with transfusional iron load. Normal intestinal 
iron absorption is about 1–2 mg/day. Patients who are poorly 
transfused, iron absorption through G.I. rises to 3–5 mg/
day or more representing an additional 1–2 g of iron loading 
per year [2,4]. Various studies have evaluated adequacy and 
effectiveness of BTs in thalassemic patients [5‑10]. In our 
country, thalassemic children are usually undertransfused [5‑9]. 
This undertransfusion further leads to more accumulation of iron 
in the body through increased absorption of dietary iron as a 
result of anemia and ineffective erythropoiesis. Hence, chelation 
therapy might become inadequate and ineffective. Complications 
of iron overload are growth retardation, failure or delay of sexual 
maturation, involvement of heart (dilated cardiomyopathy), and 
liver and endocrinal glands. Thus, chronic BTs in thalassemic 
patients are double‑edged sword requiring optimal transfusion 
with maximum benefit and minimum hazards.
Serum ferritin level is the most commonly employed test to 
evaluate iron overload in β‑TM. The association between serum 
ferritin and levels of body iron is well established [11‑13] and the 
test is easy to perform in comparison with the other tests for iron 
overload. The present study aims to evaluate iron overload and 
adequacy of PRBCs transfusion in children with TM along with 
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relationship between serum ferritin with transfusional iron load 
and pre‑transfusion hemoglobin level. This will help to overcome 
various problems related to under‑ or over‑transfusion along with 
initiation and follow‑up of proper chelation therapy [14].
MATERIALS AND METHODS
This single‑center retroprospective observational study was 
carried out in thalassemia day care center of tertiary care hospital 
in Eastern Uttar Pradesh from April 2017 to June 2018 over 
transfusion dependent β‑thalassemic patients up to 18 years of age. 
Patients with confirmed diagnosis of β‑TM based on Hb variant 
test using high‑performance liquid chromatography were included 
in the study. Patients of β‑thalassemia trait (heterozygous), 
thalassemia intermedia, and α‑thalassemia variant were excluded 
from the study. Approval for the study was obtained from the 
institutional ethics committee.
Children with confirmed diagnosis of β‑TM were enrolled 
over initial 2 months. Data of patients were recorded in a pretested 
case record form including demographic profile and details of BTs 
including number, volume of PRBC transfused, pre‑transfusion 
Hb level, and serum ferritin levels for 1 year. Newly diagnosed 
patients or patients whose previous 1 year data were not available 
were followed for 1 year to record the above parameters.
To assess the adequacy of BTs, we considered number and 
volume of PRBC transfused and mean pre‑transfusion Hb level 
in a year. We calculated annual transfusional iron load (i.e., iron 
load due to only BTs) in milligram (mg) by the formula: (number 
of transfusions in a year X volume of PRBC transfused in one 
transfusion [mL/year] ×60×1.08)/(weight × 100) as the hematocrit 
of transfused PRBC to be 60% and the estimated amount of iron 
per ml of PRBC to be 1.08 [2]. We correlated serum ferritin of 
these patients with the transfusional iron load and pre‑transfusion 
Hb level.
Data were entered into Microsoft Excel spreadsheet and 
analyzed in the statistical package for Data Analysis version 2007 
to determine the mean and standard deviations. The correlation of 
serum ferritin level with transfusional iron load and pre‑transfusion 
Hb level was determined using Pearson coefficient (r) and p value.
RESULTS
A total of 33 children were enrolled for the study, of which one 
patient lost to follow‑up. Data of 32 patients were recorded. Of 
32 patients, 24 were male and 8 were female (male:female=3:1). 
The mean age of these patients was 6.0±3.65 years and majority 
of the patients belonged to the age group of 4–6 years (n=11) 
followed by 7–10 years (n=10), as shown in Fig. 1.
Mean age at diagnosis was 13.25±8.6 months with 68% of 
children diagnosed within the 1st year of life. Average weight of 
patients was 20.7±9.72 kg. Of 32 patients, 6 patients (18.7%) 
were born of consanguineous marriage. All patients were 
undertransfused with mean pre‑transfusion Hb concentration 
of 6.4±0.23 g% which is persistent in almost all age groups. 
Average number of BTs in a year was 12.5±3.02. A total of 
21 patients (65.6%) belonging to the age group of 4–6 years and 
7–10 years were receiving monthly transfusion. With increasing 
age, frequency of transfusions also increased (Fig. 2).
The average volume of blood transfused was 112 ml/kg in 
a year (2502.3±1632 ml in a year). Children in the age group 
of 13–14 years (n=2) received an average 148.5 ml/kg in a 
year (4608±407.9 ml in a year) of BTs. Calculated average annual 
transfusional iron load was 121.3±28.9 mg/kg or 0.3 mg/kg/day 
with maximum value of 160.3 mg/kg or 0.43 mg/kg/day in 
patients of age group 13–14 years (Table 1).
Mean serum ferritin level was 1744±604.6 ng/mL. Serum 
ferritin of 6 (18.75%) children was <1000 ng/mL, 24 (75%) 
children was having level between 1000 and 2500 ng/mL, and 
2 (6.25%) children was having >2500 ng/mL. Serum ferritin 
level was significantly higher in the age group of 11–12 years and 
13–14 years as compared to the age group of 1–3 years (p<0.05). 
There was a significant positive correlation between serum ferritin 
level and transfusional iron load (r=0.4184 and p=0.017) with 
coefficient of determination r2=0.1751 (Fig. 3). Negative correlation 
was observed between serum ferritin and pre‑transfusion Hb 
level (r=−0.2624 and p=0.1537), as shown in Fig. 4.
DISCUSSION
In our study group, a male preponderance of 75% (male‑to‑female 
ratio of 3:1) was observed. Only Indian studies have reported 
male preponderance (male‑to‑female ratio of 2.5:1) up to 70% 
Figure 2: Average pre‑transfusional hemoglobin level and average 
number of blood transfusions in different age groups
Figure 1: Age and gender distribution of children with β‑thalassemia 
major (n=32)
Shukla et al. Iron overload and adequacy of packed RBC transfusion
Vol 6 | Issue 9 | September 2019 Indian J Child Health 497












of transfusion in 
year
Annual amount of 
PRBC transfused 
(hematocrit 60%) ml/kg












1–3 9.8 6.3 9 81 794.20 87.48 0.239 741
4–6 11.8 6.2 10.27 92.4 1104.70 99.85 0.273 1896
7–10 20.5 6.3 12.6 113.4 2350.60 122.47 0.335 1731
11–12 29.3 6.4 14.3 126 3654.00 136.08 0.372 2351
13–14 31 6.8 16.5 148.5 4608.00 160.38 0.439 2000
Average 20.5 6.4 12.5 112.3 2502.3 121.3 0.3 1744
St. dev. 9.72 0.23 3.02 26.81 1632.05 28.94 0.08 604.63
*Annual transfusional iron load (i.e., iron load due to only blood transfusion) in milligram (mg)
Figure 3: Relationship between serum ferritin level and transfusional 
iron load
Figure 4: Relationship between serum ferritin level and 
pre‑transfusion hemoglobin
in a year was 12.5±3.02 with majority (65.6%) of the patients 
getting monthly transfusion. This was similar to the studies done 
by Shah et al. and Mishra and Tiwari, where 62% and 55.6% of 
their patients, respectively, received monthly transfusion [7,8]. 
This frequency of BTs appears to be inadequate and need to be 
reviewed along with consideration for other relevant factors.
The average volume of PRBC transfused in our study was 
112 ml/kg/year (2502.3±113 ml/year) while Thakor et al. found 
it to be 180.3 ml/kg/year [17]. According to IAP guidelines 2006, 
the average volume of transfusion should be 180 ml/kg/year in 
non‑splenectomized patients. Hence, as per volume of transfusion, 
our children were undertransfused [18]. The rate of transfusional 
iron loading is relatively well defined in TM.
With the recommended transfusion scheme, patients usually 
receive between 100 and 200 mL of PRBCs/kg per year. This rate 
of transfusion is equivalent to 108–216 mg of iron/kg per year or 
0.30–0.59 mg/kg per day [2]. Calculated average transfusional 
iron load in our study was within the lower normal range. Several 
studies (Worwood et al., 1980; Cazzola et al., 1983; and Aldouri 
et al., 1987) have investigated the relationship between the 
magnitude of iron overload and serum ferritin concentration in 
β‑thalassemia patients with transfusional iron overload [11,12].
The mean serum ferritin level for 1 year in our study was 
1744±604.6 ng/mL with 81.5% of children having serum ferritin 
level >1000 ng/mL. The study done by Kumari et al. and Shah 
et al. also showed 82.4% and 93.7% of children, respectively, 
having serum ferritin level >1000 ng/mL [5,7]. Serum ferritin 
levels were significantly higher in the age group of 11–12 years 
and 13–14 years (p<0.05) similar to the study done by Thakor 
et al. who also found high serum ferritin in the age group of 
11–12 years [17]. A significant positive correlation of serum 
ferritin with transfusional iron load and negative correlation with 
pre‑transfusional Hb was similar to the study found in Worwood 
et al. (r=0.41 and P=0.001) and Schettini et al., respectively [12,19].
Limitation of our study is that serum ferritin is cumulative 
value of iron overload, whereas we have taken its pattern only for 
a year and we could not take other factors that might influence the 
levels such as dosing and compliance of chelation therapy since it 
was a retrospective study.
On the basis of the findings in present study we suggest that in 
TDT, adequate PRBC transfusion is needed to keep pre‑transfusion 
and 75% [8,15]. Male preponderance seen in India has been 
attributed to gender bias rather than an actual preponderance of 
disease in males. Mean age at diagnosis in our study was similar 
to the study done by Trehan et al. who observed mean age at 
diagnosis of 13.2±9.7 months with 64% of patients diagnosed 
within the 1st year of life [15].
Considering the TIF recommendation, our study showed that 
all children were undertransfused similar to the previous studies 
done by Sarkar et al. who found undertransfusion in 98.5% of 
children [6]. Shah et al. and Soni et al. showed nearly 53.5% 
and 48% of the patients were undertransfused [7,16]. Studies by 
Kumari et al. and Sarkar et al. showed mean pre‑transfusion Hb 
of 7.89±1.77 and 7 g%, respectively, similar to our study [5,6]. 
Our study shows that the mean number of PRBC transfusion 
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haemoglobin level between 9 ‑ 10.5 gm% not only for optimal 
growth and physical activities but also to minimise further iron 
overload for effective chelation therapy.
CONCLUSION
In our study, all patients were undertransfused with persistent 
high serum ferritin level. Significant positive correlation of serum 
ferritin with transfusional iron load and negative correlation with 
pre‑transfusion Hb level suggests that undertransfusion further 
leads to more accumulation of iron in the body through increased 
absorption of dietary iron as a result of anemia and ineffective 
erythropoiesis.
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